Cite
APA Citation
Ahluwalia, M., Fallah, J., Peereboom, D., Schilero, C., Ali, A., Forst, D., Wong, E., Wen, P., & Reardon, D. (n.d.). rBTT-08. A RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA (GBM). Neuro-oncology, 21, vi220. http://access.bl.uk/ark:/81055/vdc_100101668105.0x00003f